Severity of Right Heart Failure Post LVAD Implantation Predicts 1 Year Mortality
نویسندگان
چکیده
منابع مشابه
End Stage Heart Failure – Transplantation or Lvad?
Heart failure is a complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill or eject blood. According to the data from the International Society for Heart and Lung Transplantation registry, the half-life of patient survival after heart transplantation has progressively improved from 8.9 years in 1982 to a proj...
متن کاملOutcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
BACKGROUND The landmark Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial first demonstrated that implantation of left ventricular assist devices (LVADs) as destination therapy (DT) can provide survival superior to any known medical treatment in patients with end-stage heart failure who are ineligible for transplantation. In the present...
متن کاملPost-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
INTRODUCTION Natriuretic peptides are ubiquitously used for diagnosis, follow-up and prognostic assessment in various heart conditions. N-terminal pro-brain natriuretic peptide (NT-proBNP) correlates with aortic stenosis severity, however its significance after transcatheter aortic valve implantation (TAVI) is not well established. AIM We aimed to assess the prognostic value of NT-proBNP at o...
متن کاملLVAD: Left ventricular assist devices for end-stage heart failure.
Heart failure affects more than 5 million Americans with approximately 200,000 patients in end-stage disease that has failed traditional treatment. Historically, the only option for treatment was a heart transplant until left ventricular assist devices offered another option.
متن کاملRight ventricular hypertrabeculation due to right heart failure after left ventricular assist device implantation.
DESCRIPTION Hypertrabeculation/non-compaction of ventricular myocardium (HVM/NVM) is a cardiomyopathy thought to be caused by arrest of normal embryogenesis of the endocardium and myocardium between the fetal 5th and 8th weeks, resulting in persistence of multiple prominent ventricular trabeculations with deep intertrabecular recesses. The myocardium of the left ventricle is most often affected...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cardiac Failure
سال: 2016
ISSN: 1071-9164
DOI: 10.1016/j.cardfail.2016.06.369